NuVasive announces favorable resolution of patent lawsuit against Cadwell Labs NuVasive announced that it reached a settlement agreement with Cadwell Laboratories in a lawsuit involving NuVasive's patented neuromonitoring technology. NuVasive filed the lawsuit in December 2012 asserting that Cadwell infringed on the company's patented neuromonitoring technology, including the integration of nerve monitoring technology during lateral approach spine surgery. As part of the settlement reached between the parties, Cadwell has agreed to exit the lateral spine surgery market, and to no longer provide products, services, or support for lateral approach spine fusion surgeries. In addition, certain of Cadwell's future products may be required to openly attribute intellectual property ownership to NuVasive and may require a 5% fee paid to NuVasive.
News For NUVA From The Last 14 Days
Check below for free stories on NUVA the last two weeks.